- Previous Close
0.0120 - Open
0.0120 - Bid 0.0110 x --
- Ask 0.0120 x --
- Day's Range
0.0110 - 0.0120 - 52 Week Range
0.0110 - 0.0450 - Volume
2,246,351 - Avg. Volume
801,247 - Market Cap (intraday)
6.843M - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.
trivarx.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: TRI.AX
View MorePerformance Overview: TRI.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TRI.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TRI.AX
View MoreValuation Measures
Market Cap
6.84M
Enterprise Value
6.23M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.60
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-22.05%
Return on Assets (ttm)
-2.41%
Return on Equity (ttm)
-4.44%
Revenue (ttm)
2M
Net Income Avi to Common (ttm)
-440.2k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
808.54k
Total Debt/Equity (mrq)
1.71%
Levered Free Cash Flow (ttm)
-2.18M